<code id='538389A785'></code><style id='538389A785'></style>
    • <acronym id='538389A785'></acronym>
      <center id='538389A785'><center id='538389A785'><tfoot id='538389A785'></tfoot></center><abbr id='538389A785'><dir id='538389A785'><tfoot id='538389A785'></tfoot><noframes id='538389A785'>

    • <optgroup id='538389A785'><strike id='538389A785'><sup id='538389A785'></sup></strike><code id='538389A785'></code></optgroup>
        1. <b id='538389A785'><label id='538389A785'><select id='538389A785'><dt id='538389A785'><span id='538389A785'></span></dt></select></label></b><u id='538389A785'></u>
          <i id='538389A785'><strike id='538389A785'><tt id='538389A785'><pre id='538389A785'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:72
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA approves Sage Therapeutics’ rapid
          FDA approves Sage Therapeutics’ rapid

          AndrewHarnik/APTheFoodandDrugAdministrationonFridayapprovedanew,rapid-actingmedicinemadebySageTherap

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          'Null' research findings aren't empty of meaning. Let's publish them

          APStockEverymedicalresearcherdreamsofdoingstudiesorconductingclinicaltrialsthatgenerateresultssocomp